A thought-leadership discussion about the causes, treatment options, and psychological impact of alopecia areata. AllMed Senior Associate Medical Director, Eric Diamond, DPM will lead a discussion on the spectrum of alopecia areata as a cosmetic condition to a clinically functional issue, and the psychological impact alopecia areata can have on patients’ mental health with expert board-certified dermatologists and Behavioral Health Medical Director, Micah Hoffman, MD, DABPN, FAPA.
In this webinar, the panel will discuss the past, current and new treatment options for alopecia areata, including the use of JAK-2 Kinase inhibitors, and whether these treatments should be considered experimental, investigational, or unproven. You’ll learn about current medical policies regarding treatment for this condition, including why some treatments for alopecia areata are classified as cosmetic.